Tocqueville Asset Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,925
| Closed | -$293K | – | 559 |
|
|
2025
Q2 | $293K | Hold |
3,925
| – | – | ﹤0.01% | 477 |
|
|
2025
Q1 | $249K | Hold |
3,925
| – | – | ﹤0.01% | 477 |
|
|
2024
Q4 | $306K | Hold |
3,925
| – | – | ﹤0.01% | 482 |
|
|
2024
Q3 | $315K | Hold |
3,925
| – | – | 0.01% | 456 |
|
|
2024
Q2 | $325K | Hold |
3,925
| – | – | 0.01% | 448 |
|
|
2024
Q1 | $335K | Hold |
3,925
| – | – | 0.01% | 444 |
|
|
2023
Q4 | $336K | Sell |
3,925
-341
| -8% | -$29.5K | 0.01% | 440 |
|
|
2023
Q3 | $382K | Sell |
4,266
-480
| -10% | -$42.9K | 0.01% | 422 |
|
|
2023
Q2 | $404K | Sell |
4,746
-12,681
| -73% | -$1.07M | 0.01% | 430 |
|
|
2023
Q1 | $1.44M | Sell |
17,427
-6,218
| -26% | -$503K | 0.03% | 303 |
|
|
2022
Q4 | $1.86M | Sell |
23,645
-1,435
| -6% | -$115K | 0.04% | 288 |
|
|
2022
Q3 | $1.86M | Sell |
25,080
-154,750
| -86% | -$11.1M | 0.04% | 286 |
|
|
2022
Q2 | $11.7M | Hold |
179,830
| – | – | 0.21% | 113 |
|
|
2022
Q1 | $11.4M | Sell |
179,830
-55,039
| -23% | -$2.99M | 0.17% | 132 |
|
|
2021
Q4 | $12.5M | Buy |
234,869
+53,283
| +29% | +$3.25M | 0.17% | 134 |
|
|
2021
Q3 | $12.8M | Sell |
181,586
-6,016
| -3% | -$380K | 0.19% | 129 |
|
|
2021
Q2 | $12.5M | Buy |
187,602
+163,750
| +687% | +$11.6M | 0.18% | 132 |
|
|
2021
Q1 | $2.65M | Sell |
23,852
-1,212
| -5% | -$150K | 0.04% | 336 |
|
|
2020
Q4 | $2.98M | Sell |
25,064
-119
| -0.5% | -$12.8K | 0.05% | 297 |
|
|
2020
Q3 | $2.2M | Buy |
25,183
+10,985
| +77% | +$960K | 0.04% | 298 |
|
|
2020
Q2 | $1.27M | Buy |
+14,198
| New | +$1.43M | 0.03% | 359 |
|
|
2019
Q3 | – | Sell |
-4,083
| Closed | -$491K | – | 764 |
|
|
2019
Q2 | $491K | Sell |
4,083
-529
| -11% | -$52K | 0.01% | 603 |
|
|
2019
Q1 | $403K | Sell |
4,612
-209
| -4% | -$19K | 0.01% | 627 |
|
|
2018
Q4 | $482K | Buy |
4,821
+247
| +5% | +$25.9K | 0.01% | 565 |
|
|
2018
Q3 | $524K | Buy |
+4,574
| New | +$474K | 0.01% | 609 |
|
|
2015
Q4 | – | Sell |
-269,502
| Closed | -$8.71M | – | 933 |
|
|
2015
Q3 | $8.71M | Buy |
269,502
+2,935
| +1% | +$110K | 0.12% | 212 |
|
|
2015
Q2 | $11M | Buy |
266,567
+22,802
| +9% | +$961K | 0.13% | 198 |
|
|
2015
Q1 | $10.9M | Buy |
243,765
+163,739
| +205% | +$6.84M | 0.13% | 193 |
|
|
2014
Q4 | $3M | Buy |
80,026
+18,281
| +30% | +$670K | 0.03% | 405 |
|
|
2014
Q3 | $2.16M | Sell |
61,745
-325
| -0.5% | -$11.6K | 0.02% | 421 |
|
|
2014
Q2 | $2.19M | Buy |
+62,070
| New | +$2.07M | 0.02% | 465 |
|
Other funds holding HAE
RRAM
Tocqueville Asset Management's HAE Position: Q3 2025 in Review
Tocqueville Asset Management sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 3,925 shares — an estimated $293K sold.
Tocqueville Asset Management first reported a position in HAE in Q2 2014 and held it in 31 quarters. The position peaked at $12.8M in Q3 2021. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.
- Tocqueville Asset Management reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
- Tocqueville Asset Management sold 3,925 Haemonetics shares in Q3 2025, an estimated $293K.
- Tocqueville Asset Management first reported a position in Haemonetics in Q2 2014 and held it in 31 quarters.
- Tocqueville Asset Management's Haemonetics position peaked at $12.8M in Q3 2021.
- 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.
Based on Tocqueville Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.